← Back to Search

Health Services Research (survey, interview, chart review) for Acute Lymphoblastic Leukemia

N/A
Waitlist Available
Led By Melissa P Beauchemin
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start through completion of acute lymphoblastic leukemia therapy, an average of 2.5 years
Awards & highlights

Summary

The overall goals of this study are to measure parents' financial distress (worry or anxiety about money) during their child's/adolescent's treatment for acute lymphoblastic leukemia and whether it changes over time, and to learn what factors are associated with changes in financial distress. Information gathered from this study will inform future intervention studies that may mitigate financial distress for parents of children/adolescents being treated for acute lymphoblastic leukemia.

Eligible Conditions
  • Acute Lymphoblastic Leukemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from start through completion of acute lymphoblastic leukemia therapy, an average of 2.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and from start through completion of acute lymphoblastic leukemia therapy, an average of 2.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in financial distress
Secondary outcome measures
Factors associated with financial distress
Other outcome measures
Domains of financial toxicity
Parental experiences of financial distress and material hardship, and perceptions about financial screening/assessments during their child's/adolescent's treatment

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health Services Research (survey, interview, chart review)Experimental Treatment3 Interventions
Parents complete surveys over 15-30 minutes at the beginning of their child's induction chemotherapy, at the beginning of maintenance chemotherapy, and at the end of last chemotherapy. Parents may also participate in one-time individual interview over 30-45 minutes. Additionally, children's medical records are reviewed during the study

Find a Location

Who is running the clinical trial?

Children's Oncology GroupLead Sponsor
457 Previous Clinical Trials
239,730 Total Patients Enrolled
Melissa P BeaucheminPrincipal InvestigatorChildren's Oncology Group
~50 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top